Armata Pharmaceuticals Cash Flow Statement (2013-2026) | ARMP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-6.19M	-6.14M	-6.05M	-8.77M	-9.21M	-8.61M	-10.31M	-11.33M	-9.58M	-11.46M	-10.96M	-12.00M	-14.41M	-12.68M	-13.82M	-11.79M	-10.65M	-12.12M	-18.66M	-14.34M
Depreciation and Depletion (Quarter)	0.30M	0.30M	0.31M	0.23M	0.20M	0.20M	0.30M	0.20M	0.20M	0.20M	0.30M	0.30M	0.30M	0.30M	0.42M	0.38M	0.30M	0.40M	0.43M	0.46M
Share-based Compensation (Quarter)	0.91M	0.47M	0.66M	0.49M	0.95M	0.85M	0.82M	0.86M	0.26M	-0.37M	0.19M	0.53M	1.33M	0.67M	0.35M	0.78M	0.57M	0.62M	0.63M	1.07M
Gains from Sales and Divestitures (Quarter)	0.17M	0.17M	0.17M		0.02M	0.02M	0.02M		0.05M	0.05M	0.10M			0.05M	0.05M	0.02M	0.02M	0.07M	0.07M	0.02M
Gains from Investment Securities (Quarter)	0.01M	0.01M	26.00M	0.10M	0.18M	1.22M	8.62M	0.00M	0.02M	0.02M	0.06M	1.81M	0.27M	0.98M	-0.92M	0.01M	1.60M	1.60M		769.00
Non-cash Items (Quarter)	0.74M	0.73M	2.40M	0.95M	1.27M	1.29M	1.44M	1.53M	1.70M	2.14M	0.43M	3.33M	0.14M	0.01M	0.00M	2.41M	2.47M	1.62M	15.04M	2.92M
Cash from Operations (Quarter)	-4.54M	-4.96M	-8.60M	-3.52M	-8.15M	-10.33M	-10.48M	-17.57M	-12.06M	-9.69M	-8.11M	-10.58M	-10.18M	-8.86M	-7.93M	-7.58M	-7.21M	-4.30M	-6.67M	-5.78M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.30M	0.30M	0.31M	0.23M	0.20M	0.20M	0.24M	0.23M	0.23M	0.22M	0.29M	0.32M	0.32M	0.31M	0.38M	0.38M	0.37M	0.37M	0.43M	0.46M
Change in Working Capital
Change in Receivables (Quarter)
Change in Accured Expenses (Quarter)	0.51M	1.05M	-0.97M	0.94M	-0.32M	0.15M	2.90M	-0.91M	1.02M	-0.44M	-0.74M	0.18M	-2.32M	0.11M	-1.72M	-0.55M	-0.27M	0.38M	0.35M	-0.35M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)	0.11M	0.14M	0.26M	-0.72M	0.28M	1.90M	6.21M	-3.66M	5.87M	-11.93M	4.90M	-1.80M	-1.43M	-0.94M	-0.94M	-0.54M	0.03M	-0.26M	-0.27M	-0.95M
Investing Activities
Capital Expenditures (Quarter)	0.20M	0.58M	0.23M	0.24M	1.14M	1.29M	-0.46M	2.01M	0.22M	3.51M	2.40M	0.25M	1.37M	0.34M	-0.08M	0.10M	0.15M	0.24M	0.05M	0.06M
Sales of Property, Plant and Equipment (Quarter)
Cash from Investing Activities (Quarter)	-0.20M	-0.58M	-0.23M	-0.24M	-1.14M	-1.29M	0.46M	-2.01M	-0.22M	-3.51M	-2.39M	-0.25M	-1.37M	-0.34M	0.08M	-0.10M	-0.15M	-0.24M	-0.05M	-0.06M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)	-0.18M	0.09M	7.04M	44.63M	-0.15M	0.03M	-0.50M	29.59M	-0.37M	24.80M	-0.04M	34.93M	0.09M	-0.06M		9.99M		14.97M	0.66M	0.64M
Dividend Payments
Dividends Paid - Common (Quarter)
Additional items
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)	-4.92M	-5.46M	-1.79M	40.88M	-9.43M	-11.60M	-10.53M	10.01M	-12.65M	11.61M	-10.54M	24.10M	-11.46M	-9.26M	-7.85M	2.31M	-7.36M	10.43M	-6.07M	-5.20M
Free Cash Flow (Quarter)	-4.73M	-5.55M	-8.83M	-3.75M	-9.28M	-11.63M	-10.03M	-19.58M	-12.28M	-13.20M	-10.51M	-10.83M	-11.54M	-9.20M	-7.85M	-7.68M	-7.36M	-4.54M	-6.73M	-5.84M
Net Cash Flow (Quarter)	-4.92M	-5.46M	-1.79M	40.88M	-9.43M	-11.60M	-10.53M	10.01M	-12.65M	11.61M	-10.54M	24.10M	-11.46M	-9.26M	-7.85M	2.31M	-7.36M	10.43M	-6.07M	-5.20M

Research Tools

Developers

Armata Pharmaceuticals Cash Flow Statement (2013-2026) | ARMP

Research Tools

Developers

Armata Pharmaceuticals Cash Flow Statement (2013-2026) | ARMP

Create an account

Sign In

Reset Password